DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS.
The trial will use health information already collected in the NHS to reduce the time taken for research, both for patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments.
The first trial will target an important health concern, aiming to improve the health outcomes of patients with atrial fibrillation (AF), by reducing the risk of stroke, blood clots and potentially cognitive decline and vascular dementia.
DaRe2THINK is funded by the National Institute of Health Research (NIHR) Health Technology Assessment programme. The trial brings together world leading expertise from: